DexCom | 8-K: Dexcom Reports Third Quarter 2024 Financial Results
DexCom | 8-K: Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
DexCom | 8-K: Current report
DexCom | 8-K: Dexcom Reports First Quarter 2024 Financial Results
DexCom | DEF 14A: Definitive information statements
DexCom | 8-K: Current report
DexCom | 8-K: Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Dexcom Reports Second Quarter 2023 Financial Results
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Current report
DexCom | 8-K: Dexcom Reports First Quarter 2023 Financial Results
DexCom | DEFA14A: Others
No Data
No Data